Wells Fargo
AXNX

Wells Fargo’s Axonics, Inc. Common Stock AXNX Stock Holding History

Wells Fargo’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-42,507
Closed -$2.96M – 7274
2024
Q3 		$2.96M Buy
42,507
+315
+0.7% +$21.6K ﹤0.01% 2765
2024
Q2 		$2.84M Buy
42,192
+5,721
+16% +$385K ﹤0.01% 2706
2024
Q1 		$2.52M Sell
36,471
-10,892
-23% -$735K ﹤0.01% 2794
2023
Q4 		$2.95M Buy
47,363
+3,329
+8% +$186K ﹤0.01% 2599
2023
Q3 		$2.47M Sell
44,034
-5,899
-12% -$332K ﹤0.01% 2634
2023
Q2 		$2.52M Buy
49,933
+18,708
+60% +$995K ﹤0.01% 2715
2023
Q1 		$1.7M Buy
31,225
+9,373
+43% +$548K ﹤0.01% 3002
2022
Q4 		$1.37M Buy
21,852
+4,383
+25% +$291K ﹤0.01% 3048
2022
Q3 		$1.23M Buy
17,469
+5,812
+50% +$401K ﹤0.01% 3085
2022
Q2 		$661K Sell
11,657
-131,268
-92% -$7.2M ﹤0.01% 3565
2022
Q1 		$8.95M Sell
142,925
-17,733
-11% -$956K ﹤0.01% 1928
2021
Q4 		$9M Sell
160,658
-410,923
-72% -$25.1M ﹤0.01% 1962
2021
Q3 		$37.2M Buy
571,581
+414,679
+264% +$28.3M 0.01% 1239
2021
Q2 		$9.95M Buy
156,902
+90,683
+137% +$5.35M ﹤0.01% 2230
2021
Q1 		$3.97M Sell
66,219
-32,399
-33% -$1.76M ﹤0.01% 3058
2020
Q4 		$4.92M Buy
98,618
+42,303
+75% +$1.99M ﹤0.01% 2774
2020
Q3 		$2.87M Buy
56,315
+8,199
+17% +$342K ﹤0.01% 3020
2020
Q2 		$1.69M Buy
48,116
+228
+0.5% +$7.85K ﹤0.01% 3392
2020
Q1 		$1.22M Sell
47,888
-137
-0.3% -$4.07K ﹤0.01% 3409
2019
Q4 		$1.33M Buy
48,025
+5,561
+13% +$133K ﹤0.01% 3660
2019
Q3 		$1.14M Buy
42,464
+5,069
+14% +$177K ﹤0.01% 3737
2019
Q2 		$1.53M Sell
37,395
-5,483
-13% -$154K ﹤0.01% 3555
2019
Q1 		$1.03M Buy
42,878
+27,636
+181% +$501K ﹤0.01% 3859
2018
Q4 		$231K Buy
+15,242
New +$227K ﹤0.01% 4825

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Wells Fargo's AXNX Position: Q4 2024 in Review

Wells Fargo sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 42,507 shares — an estimated $2.96M sold.

Wells Fargo first reported a position in AXNX in Q4 2018 and held it in 24 quarters. The position peaked at $37.2M in Q3 2021. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Wells Fargo reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Wells Fargo sold 42,507 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.96M.
  • Wells Fargo first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • Wells Fargo's Axonics, Inc. Common Stock position peaked at $37.2M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.